India Eyes Overhaul of Drug Advertising Rules, Ban on High-Risk Medicines Online Proposed

Overview

The Indian government is planning significant changes to drug advertising regulations, aiming to ban promotions of high-risk medications like potent antibiotics and hormonal therapies on online platforms. This move intends to curb self-medication, unsafe sales, and combat antimicrobial resistance, affecting e-pharmacies and the pharmaceutical sector.